| Product Code: ETC8631814 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of parenteral lipid emulsion to Nigeria in 2024 saw significant contributions from top exporting countries like India, China, Netherlands, Metropolitan France, and the USA. Despite a negative Compound Annual Growth Rate (CAGR) of -26.13% from 2020 to 2024, the market maintained high concentration with a stable Herfindahl-Hirschman Index (HHI). The growth rate in 2024, at -30.33%, indicates a slight decline from the previous year. This data suggests a consistent demand for parenteral lipid emulsion in Nigeria, with key players continuing to dominate the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Parenteral Lipid Emulsion Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Parenteral Lipid Emulsion Market - Industry Life Cycle |
3.4 Nigeria Parenteral Lipid Emulsion Market - Porter's Five Forces |
3.5 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume Share, By Ingredient, 2021 & 2031F |
4 Nigeria Parenteral Lipid Emulsion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of chronic diseases requiring parenteral nutrition, leading to a higher demand for parenteral lipid emulsions in Nigeria. |
4.2.2 Growth in the geriatric population in Nigeria, who are more prone to malnutrition and require parenteral nutrition support. |
4.2.3 Rising healthcare infrastructure and increasing investments in healthcare facilities, enhancing the availability and access to parenteral lipid emulsions. |
4.3 Market Restraints |
4.3.1 Limited awareness among healthcare professionals and patients about the benefits and appropriate use of parenteral lipid emulsions. |
4.3.2 High cost associated with parenteral lipid emulsions, which may limit affordability for some patients or healthcare facilities. |
5 Nigeria Parenteral Lipid Emulsion Market Trends |
6 Nigeria Parenteral Lipid Emulsion Market, By Types |
6.1 Nigeria Parenteral Lipid Emulsion Market, By Ingredient |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume, By Ingredient, 2021- 2031F |
6.1.3 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume, By 1st generation lipid emulsions, 2021- 2031F |
6.1.4 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume, By 2nd generation lipid emulsions, 2021- 2031F |
6.1.5 Nigeria Parenteral Lipid Emulsion Market Revenues & Volume, By 3rd generation lipid emulsions, 2021- 2031F |
7 Nigeria Parenteral Lipid Emulsion Market Import-Export Trade Statistics |
7.1 Nigeria Parenteral Lipid Emulsion Market Export to Major Countries |
7.2 Nigeria Parenteral Lipid Emulsion Market Imports from Major Countries |
8 Nigeria Parenteral Lipid Emulsion Market Key Performance Indicators |
8.1 Number of hospitals and healthcare facilities offering parenteral nutrition services using lipid emulsions. |
8.2 Percentage of healthcare professionals trained in the appropriate use and administration of parenteral lipid emulsions. |
8.3 Patient satisfaction scores related to the availability, quality, and effectiveness of parenteral lipid emulsions in healthcare settings. |
9 Nigeria Parenteral Lipid Emulsion Market - Opportunity Assessment |
9.1 Nigeria Parenteral Lipid Emulsion Market Opportunity Assessment, By Ingredient, 2021 & 2031F |
10 Nigeria Parenteral Lipid Emulsion Market - Competitive Landscape |
10.1 Nigeria Parenteral Lipid Emulsion Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Parenteral Lipid Emulsion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |